Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Altimmune (ALT1) Drug Pipeline

0 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
PemvidutideMetabolic Dysfunction-Associated Steatohepatitis (Mash)Phase IIIRecruitingPhase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASHAug 14, 2026―
PemvidutideAlcohol Liver DiseasePhase IIActive Not RecruitingRESTORE TRIAL: Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)Jun 05, 2025
PemvidutideAlcohol Use Disorder (Aud)Phase IICompletedRECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or OverweightMay 16, 2025
PemvidutideNon-Alcoholic Steatohepatitis (Nash)Phase IICompletedIMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)Jul 24, 2023
Alt-801Type 2 DiabetesPhase ICompletedALT-801 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus (T2DM)Nov 15, 2021―
Metformin, Digoxin, Warfarin, Atorvastatin, Pemvidutide, Ethinylestradiol And LevonorgestrelNash - Nonalcoholic SteatohepatitisPhase ICompletedPemvidutide (ALT-801) DDI Study in Healthy VolunteersJul 14, 2021―
Alt-801Obesity, Nonalcoholic SteatohepatitisPhase ICompletedALT-801 (Pemvidutide) in Healthy Overweight and Obese Volunteers to Study Safety and TolerabilitySep 16, 2020―
NasoshieldHealthy VolunteersPhase ICompletedNasoShield in Healthy Adults to Study Safety and ImmunogenicityJun 01, 2020―
Biothrax, NasoshieldHealthy VolunteersPhase ICompletedNasoShield Study of Safety and ImmunogenicityNov 21, 2017―
Fp-02.2 Vaccine, Ic31 AdjuvantHepatitis BPhase ICompletedPhase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis BJul 06, 2015―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Altimmune (MX:ALT1) have in its pipeline
Altimmune MX:ALT1 is currently developing the following drugs: Pemvidutide, Alt-801, Metformin, Digoxin, Warfarin, Atorvastatin, Pemvidutide, Ethinylestradiol And Levonorgestrel, Nasoshield, Biothrax, Nasoshield, Fp-02.2 Vaccine, Ic31 Adjuvant, Pandemic Influenza Vaccine. These drug candidates are in various stages of clinical development as the company works toward FDA approval.